Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anticoagulation regimens for prosthetic heart valve non-obstructive thrombosis
NCT02240953Unknown
- Sponsor
- Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
- Start
- Jan 2009
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in prosthetic heart valve thrombosis (PHVT), sponsored by Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi. Primary endpoint: Decreased thrombus size at 6 months. Status: unknown.
02
Drugs
aspirin
03
Conditions
prosthetic heart valve thrombosis (PHVT)
Beyond the preview
Go deeper on NCT02240953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02240953.